Skip to main content

You must be a logged-in member of UHMS or a subscriber to the UHMS Journal in order to download the articles listed within these pages. If you are a member or subscriber, please log in using the Log In button above. If you would like to purchase a membership or a subscription, use the buttons below.

Join the UHMS
Purchase a Subscription

Search UHM/UBR

Hyperbaric oxygen therapy for treatment of COVID-19-related parosmia: a case report

ABSTRACT

Krimus L, Rizvi SH, Marinov A, Clarke H, Katznelson R. Hyperbaric oxygen therapy for treatment of COVID-19-related parosmia: a case report. Undersea Hyperb Med. 2023 Fourth Quarter; 50(4):433- 435.

Parosmia is a qualitative olfactory dysfunction characterized by distortion of odor perception. Traditional treatments for parosmia include olfactory training and steroids. Some patients infected with COVID-19 have developed chronic parosmia as a result of their infection. Here, we present the case of
a patient who developed parosmia after a COVID-19 infection that was not improved by traditional treatments but found significant improvement after hyperbaric oxygen therapy[A1].

Keywords: COVID-19; hyperbaric oxygen therapy; parosmia